Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...

Asthma: Pathogenesis and Management

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...

Asthma-IV: Diagnostic and Management

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:

Asthma-I: Introduction

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...

COPD: Management Using Bronchodilators and Corticosteroids

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Pulmonary monocyte kinetics in healthy volunteers and subjects with inflammatory arthritis.

Thorax·2026

Same author

Neurological impact of sub-chronic lead acetate exposure on pain perception in mice.

Toxicology reports·2025

Same author

Correction: β-Lapachone protects against doxorubicin-induced nephrotoxicity via NAD<sup>+</sup>/AMPK/NF-kB in mice.

Naunyn-Schmiedeberg's archives of pharmacology·2024

Same author

Regulation of ICAM-1 in human neutrophils.

Journal of leukocyte biology·2024

Same author

Publisher Correction: Elucidating mechanisms of genetic cross-disease associations at the PROCR vascular disease locus.

Nature communications·2022

Same author

Elucidating mechanisms of genetic cross-disease associations at the PROCR vascular disease locus.

Nature communications·2022

Search research articles

Related Experiment Video

Updated: May 9, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

Asthma: beyond corticosteroid treatment.

Yasser Marandi¹, Neda Farahi, Goudarz Sadeghi Hashjin

¹Department of Pharmacology, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Archives of Medical Science : AMS

|July 13, 2013

Summary

This summary is machine-generated.

Asthma affects over 300 million globally. This review covers current asthma treatments and explores new therapies due to limitations of existing corticosteroid treatments.

Keywords:

asthma corticosteroids inflammation

Related Experiment Videos

Last Updated: May 9, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

Area of Science:

Pulmonology and Respiratory Medicine
Clinical Pharmacology

Background:

Asthma is a prevalent chronic respiratory disease affecting over 300 million individuals worldwide.
It is characterized by airway inflammation, bronchoconstriction, and hyperresponsiveness.
Current treatments, primarily corticosteroids, have limitations including side effects and resistance.

Purpose of the Study:

To review current asthma treatment strategies.
To explore novel therapeutic regimens in the asthma drug development pipeline.

Main Methods:

Literature review of existing asthma therapies.
Analysis of emerging treatments for asthma management.

Main Results:

Corticosteroids are the primary treatment but have significant limitations.
A growing need exists for more effective asthma therapies.
New drug development targets various pathways in asthma.

Conclusions:

There is a critical need for improved asthma treatments beyond corticosteroids.
Emerging therapies show promise for managing asthma effectively.
Further research and development are essential for advancing asthma care.